当旅行虫害让你失望时:严重的,低血压的非洲咬热和对治疗的反应
Sarthak Singh Saxena, Sofia Zeidan, Summer Meyer
1Department of Dermatology, University of California Davis Health, Sacramento, California, USA. DTartar@ucdavis.edu.
Dermatology online journal
|March 13, 2024
概括
非洲咬热 (ATBF) 是一种由传播的疾病. 这一案例突出了一个被诊断为ATBF的美国旅行者呈现低血压,这是一个罕见的症状,成功地用多西环林治疗.
科学领域:
- 传染性疾病 传染性疾病
- 旅行 医学 旅行 医学
- 里克塞斯病毒感染.
背景情况:
- 非洲咬热 (ATBF) 是由Rickettsia africae引起的,在撒哈拉以南非洲普遍存在.
- 从流行地区返回的旅行者可能会出现不典型的症状.
- 早期诊断和治疗对于患者的康复至关重要.
研究的目的:
- 在美国旅行者中报告非洲咬热病例.
- 突出症状性低血压作为ATBF的潜在表现.
- 强调旅行史在诊断发烧性疾病中的重要性.
主要方法:
- 从津巴布韦返回的美国旅行者的案例介绍.
- 临床评估包括症状 (发烧,疲劳,死角性,低血压) 和他的病理学.
- 使用口服多克西环林的治疗.
主要成果:
- 患者出现了发烧,疲劳,死性,以及症状性低血压.
- 非洲咬热的诊断得到证实.
- 经过口服多克西环林治疗后,症状迅速消失.
结论:
- 这一病例代表了与症状性低血压相关的非洲咬热病的首例.
- 医生应该考虑ATBF发烧的旅行者从流行地区返回,即使有不寻常的症状.
- 及时评估旅行史对于准确诊断和传染病管理至关重要.
相关概念视频
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Methods of reducing fever
662
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
662
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
164
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
164
Increased Body Temperature
667
A body temperature above 38°C (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
667
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
161
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
161


